Evidence map›Paper›PMID 20471053›Full record

ArticleVirology2010

In vivo depletion of CD4(+)CD25(hi) regulatory T cells is associated with improved antiviral responses in cats chronically infected with feline immunodeficiency virus.

S Rochelle Mikkelsen, Stacie K Reckling, Erin A Egan, Gregg A Dean

Open access · greenAbstract read
In one paragraph

Article in Virology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.7field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 15 citations in OpenAlex.

  1. Immunoregulatory Cells in Myasthenia Gravis.Frontiers in neurology · 2020
    Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Host immune responses that promote initial HIV spread.Journal of theoretical biology · 2011
    Article
  9. Article
  10. Regulatory T cells in infection.Advances in immunology · 2011
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

S Rochelle MikkelsenCollege of Veterinary Medicine, North Carolina State University, Raleigh, NC 27606, USA. rmikkelsen@globalvaccines.org
Stacie K Reckling
Erin A Egan
Gregg A Dean
North Carolina State University · US

Funding

Molecular Biotechnology Training at North Carolina State UniversityT32GM008776 · NIGMS · NORTH CAROLINA STATE UNIVERSITY RALEIGH · PI KELLY, ROBERT M · 2000 to 2019
$3.9M
BASIS AND MODULATION OF THE INNATE IMMUNE DEFECT IN FIVR01AI047707 · NIAID · NORTH CAROLINA STATE UNIVERSITY RALEIGH · PI DEAN, GREGG A · 2001 to 2010
$2.5M
In vivo significance of T-reg cells during FIV infectionR21AI065223 · NIAID · NORTH CAROLINA STATE UNIVERSITY RALEIGH · PI DEAN, GREGG A · 2005 to 2006
$577k
NIAID NIH HHS AI065223NIAID NIH HHS AI47707NIAID NIH HHS R01 AI047707NIAID NIH HHS R21 AI065223NIGMS NIH HHS GM008776NIGMS NIH HHS T32 GM008776
6 · The paper itself

Abstract

Regulatory T (Treg) cells are activated and suppress immune responses during infection, and are characterized as CD4(+)CD25(hi)FOXP3(+). Ex vivo studies demonstrate that Treg cells potentially suppress anti-HIV-1 T cell responses. Lentivirus-induced CD4(+)CD25(hi) Treg cells were first described in feline immunodeficiency virus (FIV)-infected cats. In the present study we demonstrate that anti-feline CD25 monoclonal antibody (mAb) therapy depletes Treg cells in FIV-infected cats for 4 weeks and does not exacerbate viral replication or proinflammatory cytokine production. Significant FIV-specific immune responses are revealed in Treg cell-depleted cats. These anti-FIV effector cells exist prior to Treg cell depletion and are not expanded while Treg cells are depleted. Importantly, cats receiving the Treg cell-depleting mAb are able to produce a robust humoral response to new antigen. We propose that short-term in vivo Treg cell depletion during chronic HIV-1 infection could provide a window of opportunity for therapeutic vaccination in individuals with controlled viral replication.

Indexed as

Lymphocyte DepletionAnimalsAntibodies, MonoclonalAntibodies, ViralCat DiseasesCatsCD4 AntigensFemaleImmunodeficiency Virus, FelineInterleukin-2 Receptor alpha SubunitLentivirus InfectionsT-Lymphocytes, RegulatoryAntibodies, MonoclonalAntibodies, ViralCD4 AntigensInterleukin-2 Receptor alpha Subunit

Identifiers

PMID20471053
PMCPMC2879469
OpenAlexW1964434077

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.